These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 23243267

  • 21. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [Abstract] [Full Text] [Related]

  • 22. Atypical hemolytic uremic syndrome: Korean pediatric series.
    Lee JM, Park YS, Lee JH, Park SJ, Shin JI, Park YH, Yoo KH, Cho MH, Kim SY, Kim SH, Namgoong MK, Lee SJ, Lee JH, Cho HY, Han KH, Kang HG, Ha IS, Bae JS, Kim NK, Park WY, Cheong HI.
    Pediatr Int; 2015 Jun; 57(3):431-8. PubMed ID: 25443527
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.
    Sugawara Y, Kato H, Nagasaki M, Yoshida Y, Fujisawa M, Minegishi N, Yamamoto M, Nangaku M.
    J Hum Genet; 2023 Jun; 68(6):427-430. PubMed ID: 36755127
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The autoimmune disease DEAP-hemolytic uremic syndrome.
    Skerka C, Zipfel PF, Müller D, Micklisch S, Riedl M, Zimmerhackl LB, Hofer J.
    Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
    [Abstract] [Full Text] [Related]

  • 28. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
    Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon-Durey MA, Bagga A, Indian HUS Registry.
    Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
    [Abstract] [Full Text] [Related]

  • 29. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
    Fung WW, Chao AC, Pang WF, Wong RS, Chow KM, Szeto CC.
    BMC Nephrol; 2024 May 14; 25(1):164. PubMed ID: 38745129
    [Abstract] [Full Text] [Related]

  • 30. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
    Krid S, Roumenina LT, Beury D, Charbit M, Boyer O, Frémeaux-Bacchi V, Niaudet P.
    Am J Transplant; 2012 Jul 14; 12(7):1938-44. PubMed ID: 22494769
    [Abstract] [Full Text] [Related]

  • 31. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B.
    Pouw RB, Gómez Delgado I, López Lera A, Rodríguez de Córdoba S, Wouters D, Kuijpers TW, Sánchez-Corral P.
    Front Immunol; 2018 Jul 14; 9():848. PubMed ID: 29740447
    [Abstract] [Full Text] [Related]

  • 32. Copy number variation analysis using next-generation sequencing identifies the CFHR3/CFHR1 deletion in atypical hemolytic uremic syndrome: a case report.
    Park J, Yhim HY, Kang KP, Bae TW, Cho YG.
    Hematology; 2022 Dec 14; 27(1):603-608. PubMed ID: 35617302
    [Abstract] [Full Text] [Related]

  • 33. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
    Francis NJ, McNicholas B, Awan A, Waldron M, Reddan D, Sadlier D, Kavanagh D, Strain L, Marchbank KJ, Harris CL, Goodship TH.
    Blood; 2012 Jan 12; 119(2):591-601. PubMed ID: 22058112
    [Abstract] [Full Text] [Related]

  • 34. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S.
    J Am Soc Nephrol; 2018 Jan 12; 29(1):240-249. PubMed ID: 28993505
    [Abstract] [Full Text] [Related]

  • 35. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y.
    Mol Immunol; 2013 Jun 12; 54(2):238-46. PubMed ID: 23314101
    [Abstract] [Full Text] [Related]

  • 36. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2012 Aug 12; 27(8):1283-91. PubMed ID: 22410797
    [Abstract] [Full Text] [Related]

  • 37. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.
    Leban N, Abarrategui-Garrido C, Fariza-Requejo E, Amiñoso-Carbonero C, Pinto S, Chibani JB, Khelil AH, Sánchez-Corral P.
    Int J Immunogenet; 2012 Apr 12; 39(2):110-3. PubMed ID: 22136554
    [Abstract] [Full Text] [Related]

  • 38. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
    Guo WY, Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Wang SX, Yu F, Zhao MH, Chinese Renal-TMA Network.
    Pediatr Nephrol; 2019 Feb 12; 34(2):269-281. PubMed ID: 30315407
    [Abstract] [Full Text] [Related]

  • 39. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 12; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 40. Successful treatment of DEAP-HUS with eculizumab.
    Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C.
    Pediatr Nephrol; 2014 May 12; 29(5):841-51. PubMed ID: 24249282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.